lactic acid has been researched along with kaempferol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Jiang, B; Jiang, BH; Li, B; Li, Z; Luo, H | 1 |
| Chen, L; Fuchs, PM; Kanazirska, MV; Lal, S; Vassilev, PM; Verma, J | 1 |
2 other study(ies) available for lactic acid and kaempferol
| Article | Year |
|---|---|
Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Female; Humans; Kaempferols; Lactic Acid; Nanoparticles; Ovarian Neoplasms; Ovary; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propylene Glycols | 2012 |
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Drug Carriers; Endosomes; Humans; Kaempferols; Lactic Acid; Lysosomes; Memantine; Mifepristone; Nanoparticles; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Resveratrol; Stilbenes | 2012 |